Outcome of third renal allograft retransplants versus primary transplants from paired donors

Transplantation

Volumn 87, Issue 8, 2009, Pages 1214-1220

  Horovitz, David ^a   Caumartin, Yves ^a   Warren, Jeff ^b,c   Sheikh, Adeel A ^d   Bloch, Michael ^b   Kapoor, Anil ^d   Jevnikar, Anthony M ^a,b   Luke, Patrick P W ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Complications; Kidney transplantation; Retransplantation

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; OKT 3; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE ANTIBODY MEDIATED REJECTION; ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RETRANSPLANTATION; SURGICAL MORTALITY; SURVIVAL; WOUND INFECTION; ALLOTRANSPLANTATION; BLEEDING; BLOOD TRANSFUSION; CANADA; FACTUAL DATABASE; FOLLOW UP; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTRAOPERATIVE PERIOD; KIDNEY TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; REOPERATION; STATISTICS; SURVIVOR; TREATMENT OUTCOME;

ADULT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; INTRAOPERATIVE PERIOD; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ONTARIO; REOPERATION; SURVIVAL ANALYSIS; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65549115963     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819f0f5c     Document Type: Article

References (40)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Russell JD, Beecroft ML, Ludwin D, et al. The quality of life in renal transplantation-A prospective study. Transplantation 1992; 54: 656.
3. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589.
4. Andreoni KA, Brayman KL, Guidinger MK, et al. Kidney and pancreas transplantation in the United States, 1996-2005.AmJ Transplant 2007; 7(5 Pt 2): 1359.
5. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289.
6. Magee JC, Barr ML, Basadonna GP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007; 7(5 Pt 2): 1424.
7. Abouljoud MS, Deierhoi MH, Hudson SL, et al. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995; 60: 138.
8. Farney AC, Noreen HJ, Sutherland DE, et al. Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival. Transplant Proc 1993; 25(1 Pt 1): 213.
9. Etienne T, Goumaz C, Ruedin P, et al. Renal retransplantation in Switzerland: Poor HLA matching of first and subsequent allografts does not appear to affect overall graft survival. Transpl Int 1992; 5(suppl 1): S65.
10. Langley J, Vergne-Marini P, Dickerman RM, et al. Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts. Transplant Proc 1991; 23: 1757.
11. Jaklitsch MT, Deierhoi MH, Hudson S, et al. Early graft function in primary and regraft recipients of paired cadaveric kidneys. Transplant Proc 1989; 21(1 Pt 2): 1274.
12. Stratta RJ, Oh CS, Sollinger HW, et al. Kidney retransplantation in the cyclosporine era. Transplantation 1988; 45: 40.
13. Miles CD, Schaubel DE, Jia X, et al. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant 2007; 7: 1140.
14. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002: 335.
15. Cecka JM, Terasaki PI. Improvement of kidney transplant regraft results by using trauma death donors. Transplantation 1987; 44: 792.
16. El-Agroudy AE, Wafa EW, Bakr MA, et al. Living-donor kidney retransplantation: Risk factors and outcome. BJU Int 2004; 94: 369.
17. Rigden S, Mehls O, Gellert R. Factors influencing second renal allograft survival. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14: 566.
18. Candinas D, Weber M, Inderbitzin D, et al. [Kidney retransplantation in relation to organ shortage]. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 1571.
19. Almond PS, Matas AJ, Gillingham K, et al. Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 1991; 52: 253.
20. Mouquet C, Benalia H, Chartier-Kastler E, et al. [Renal retransplantation in adults. Comparative prognostic study]. Prog Urol 1999; 9: 239.
21. Karakayali H, Moray G, Demirag A, et al. Long-term renal retransplantation and graft survival rates at our center. Transplant Proc 1998; 30: 762.
22. Jirasiritham S, Sumethkul V, Mavichak V, et al. Renal retransplantation. Transplant Proc 1998; 30: 3112.
23. Bryan CF, Baier KA, Nelson PW, et al. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation 1998; 66: 1827.
24. Rao PS, Schaubel DE, Saran R. Impact of graft failure on patient survival on dialysis: A comparison of transplant-naive and post-graft failure mortality rates. Nephrol Dial Transplant 2005; 20: 387.
25. Rao PS, Schaubel DE, Wei G, et al. Evaluating the survival benefit of kidney retransplantation. Transplantation 2006; 82: 669.
26. Ojo A, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analyses from the United States Renal Data System. Transplantation 1998; 66: 1651.
27. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
28. Organ Procurement and Transplant Network. Kidney Kaplan-Meier graft survival rates for transplants performed: 1997-2004: United Network for Organ Sharing. Available at: http://www.unos.org., 2007. Accessed May 2008.
29. Mazzucchi E, Danilovic A, Antonopoulos IM, et al. Surgical aspects of third and subsequent renal transplants performed by the extraperitoneal access. Transplantation 2006; 81: 840.
30. Pour-Reza-Gholi F, Nafar M, Saeedinia A, et al. Kidney retransplantation in comparison with first kidney transplantation. Transplant Proc 2005; 37: 2962.
31. Matas AJ, Gillingham KJ, Payne WD, et al. A third kidney transplant: Cost-effective treatment for end-stage renal disease? Clin Transplant 1996; 10(6 Pt 1): 516.
32. Ghods AJ, Savaj S, Abbasi M, et al. The incidence and risk factors of delayed graft function in 689 consecutive living unrelated donor renal transplantation. Transplant Proc 2007; 39: 846.
33. Lopez-Hoyos M, Fernandez-Fresnedo G, Rodrigo E, et al. Effect of delayed graft function in hypersensitized kidney transplant recipients. Hum Immunol 2005; 66: 371.
34. Lebranchu Y, Halimi JM, Bock A, et al. Delayed graft function: Risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational Study. Transplant Proc 2005; 37: 345.
35. Siernko J. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney]. Ann Acad Med Stetin 2004; 50: 53.
36. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
37. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697.
38. Hagan C, Hickey DP, Little DM. A single-center study of the technical aspects and outcome of third and subsequent renal transplants. Transplantation 2003; 75: 1687.
39. Stephanian E, Matas AJ, Gores P, et al. Retransplantation as a risk factor for lymphocele formation. Transplantation 1992; 53: 676.
40. Ahn HJ, Kim YS, Rha KH, et al. Technical refinement for third kidney transplantation. Urology 2006; 68: 189.